HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandro Pini Selected Research

3- (2- ethylphenoxy)- 1- (1,2,3,4- tetrahydronaphth- 1- ylamino)- 2- propanol oxalate

12/2020Effect of Beta 3 Adrenoreceptor Modulation on Patency of the Ductus Arteriosus.
1/2020β3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P2 modulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandro Pini Research Topics

Disease

24Neoplasms (Cancer)
01/2022 - 09/2007
14Infections
03/2020 - 07/2012
12Inflammation (Inflammations)
11/2020 - 06/2012
10Fibrosis (Cirrhosis)
01/2019 - 12/2010
8Marfan Syndrome (Marfan's Syndrome)
01/2020 - 04/2015
6Pneumonia (Pneumonitis)
01/2020 - 12/2010
5Airway Remodeling
01/2019 - 12/2010
4Sepsis (Septicemia)
01/2020 - 07/2012
4Diabetic Nephropathies (Diabetic Nephropathy)
05/2019 - 01/2018
4Bacterial Infections (Bacterial Infection)
01/2019 - 12/2013
4Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2017 - 12/2010
4Necrosis
01/2017 - 05/2012
4Reperfusion Injury
11/2013 - 05/2012
3Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2022 - 10/2014
3Asthma (Bronchial Asthma)
01/2022 - 06/2012
3Hypoxia (Hypoxemia)
01/2022 - 01/2017
3Breast Neoplasms (Breast Cancer)
11/2020 - 12/2015
3Inborn Genetic Diseases (Disease, Hereditary)
01/2020 - 01/2018
3Melanoma (Melanoma, Malignant)
01/2020 - 06/2014
3Immune System Diseases (Immune Disorders)
01/2019 - 11/2014
3Cystic Fibrosis (Mucoviscidosis)
01/2018 - 12/2015
3Heart Failure
11/2013 - 09/2012
2Disease Progression
01/2022 - 05/2014
2Hemangioma (Angioma)
01/2022 - 01/2022
2Wounds and Injuries (Trauma)
12/2021 - 11/2020
2Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 01/2016
2Diabetic Retinopathy (Retinopathy, Diabetic)
01/2020 - 05/2012
2Thoracic Aortic Aneurysm
01/2020 - 09/2018
2Infarction (Infarctions)
09/2012 - 09/2009
2Pain (Aches)
06/2012 - 05/2012
1Aortic Diseases
06/2022
1Rupture
11/2021
1Hypertension (High Blood Pressure)
11/2021
1Hyperlipidemias (Hyperlipidemia)
11/2021
1Hyperglycemia
10/2021
1Multiple Sclerosis
01/2021
1Demyelinating Diseases (Demyelinating Disease)
01/2021
1Thyroid Diseases (Thyroid Disease)
01/2021
1Triple Negative Breast Neoplasms
11/2020

Drug/Important Bio-Agent (IBA)

23Peptides (Polypeptides)IBA
12/2020 - 04/2006
19Pharmaceutical PreparationsIBA
01/2020 - 09/2007
7Bleomycin (Blenoxane)FDA LinkGeneric
01/2019 - 12/2010
7CollagenIBA
01/2017 - 05/2012
6Antimicrobial PeptidesIBA
03/2020 - 04/2010
6Proteins (Proteins, Gene)FDA Link
01/2018 - 03/2012
6CytokinesIBA
01/2017 - 04/2010
5Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
12/2020 - 01/2016
5Fibrillin-1IBA
01/2020 - 04/2015
5Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 08/2013
5NeurotensinIBA
01/2015 - 09/2007
4Retinaldehyde (Retinal)IBA
01/2022 - 05/2012
4SmokeIBA
11/2021 - 12/2015
4GlycosaminoglycansIBA
12/2020 - 06/2013
4LigandsIBA
11/2020 - 01/2016
4Heparin (Liquaemin)FDA LinkGeneric
11/2020 - 09/2012
4Biological ProductsIBA
01/2020 - 09/2007
4Histamine H4 ReceptorsIBA
01/2019 - 11/2014
4LipopolysaccharidesIBA
12/2016 - 06/2009
4RelaxinIBA
11/2013 - 12/2010
3Transforming Growth Factors (Transforming Growth Factor)IBA
06/2022 - 11/2014
3Adrenergic Receptors (Adrenergic Receptor)IBA
01/2022 - 01/2020
3Propranolol (Inderal)FDA LinkGeneric
01/2022 - 10/2014
3Particulate MatterIBA
01/2022 - 01/2021
3Histamine (Histamine Dihydrochloride)FDA Link
02/2019 - 01/2016
3Interleukin-6 (Interleukin 6)IBA
01/2017 - 05/2012
3Peroxidase (Myeloperoxidase)IBA
01/2016 - 09/2012
2Oxygen (Dioxygen)IBA
01/2022 - 01/2020
2AutoantibodiesIBA
01/2021 - 10/2017
23- (2- ethylphenoxy)- 1- (1,2,3,4- tetrahydronaphth- 1- ylamino)- 2- propanol oxalateIBA
12/2020 - 01/2020
2Interleukin-10 (Interleukin 10)IBA
11/2020 - 11/2013
2Paclitaxel (Taxol)FDA LinkGeneric
02/2020 - 12/2015
2Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
01/2020 - 01/2019
2Colistin (Coly-Mycin)FDA Link
08/2019 - 10/2017
21- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA
01/2019 - 11/2014
2AnticoagulantsIBA
01/2018 - 09/2012
2Methotrexate (Mexate)FDA LinkGeneric
09/2017 - 01/2015
2InterleukinsIBA
01/2017 - 11/2013
2human serelaxin proteinIBA
05/2016 - 01/2016
2Naproxen (Naprosyn)FDA LinkGeneric
11/2014 - 05/2012
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2014 - 05/2012
2CeramidesIBA
05/2014 - 09/2010
2Anti-Infective Agents (Microbicides)IBA
12/2013 - 07/2012
2AntioxidantsIBA
07/2013 - 05/2012
2Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2012 - 05/2012
1XenobioticsIBA
01/2022
1Explosive Agents (Explosives)IBA
12/2021
1Aquaporins (Water Channels)IBA
10/2021
1Sodium-Hydrogen ExchangersIBA
10/2021
1Low Density Lipoprotein Receptor-Related Protein-2IBA
10/2021
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
01/2021
1SyndecansIBA
12/2020
1A73025IBA
12/2020
1Antineoplastic Agents (Antineoplastics)IBA
12/2020
1Cisplatin (Platino)FDA LinkGeneric
11/2020
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2020

Therapy/Procedure

12Therapeutics
02/2020 - 09/2007
4Precision Medicine
02/2020 - 06/2013
2Quantum Dots (Quantum Dot)
02/2020 - 03/2018
1Vascular Surgical Procedures
11/2021
1Drug Therapy (Chemotherapy)
02/2020